RE:RE:RE:Wowser ! Dibah, the equity raise on Nasdaq would be after Ryplazim approval and consequently his reception could be warmer than what you say.
Anyway you look at it, I can't see TV bailing when the prospect of Ryplazim approval is within touching distance and so many 10s of millions have been invested to get to this point.
Let's see what Galbraith has to say at the upcoming Q3 results call as no doubt the declining cash runway must be the priority. In the interim, the sp continues to crash and the pain continues.